— GROWTH STRATEGY • Venturing & Innovation
The next growth platform has to be built
before you need it.
The organizations that compound growth over time don't wait for the current model to plateau. They build alongside it — finding the right bets early, and building the capability to act on them repeatedly.
— THE WORK
Two distinct problems. Most organizations solve one. Few solve both.
The first problem is finding the right innovations to pursue — identifying where the next platform is forming before the window closes, and building the strategy to get there.
The second is building the organizational capability to do it repeatedly — governance, process, and operating model that turns a one-time venturing commitment into a compounding innovation capability.
Vaxa works on both. The approach to each is different. The connection between them is what makes either one durable.
Finding the right bets
Identifying the technology horizons, market adjacencies, and structural shifts worth pursuing — before they are obvious enough that others have moved.
Building the capability to act
The governance, intake criteria, and conversion pathways that make corporate innovation a repeatable capability — not a pilot that never scales.
The connection between them
Innovation capability without strategic direction produces a portfolio of interesting experiments. Strategic direction without capability produces a plan that never executes.
— Strategic Innovation
Vaxa's proprietary process — applied inside some of the world's largest innovation-led organizations.
01
Future Foresight
Reading the signals that precede structural market shifts — technology trajectories, venture activity, regulatory movement, and adjacency patterns — before they consolidate into trends others can see.
02
Market Insights
Understanding where the opportunity actually sits — the unmet needs, underserved segments, and white space that define where a new platform can take hold and grow.
03
Strategic Alignment
Connecting the external opportunity to where the organization can credibly go — capabilities, assets, and appetite that make the innovation bet executable, not just attractive.
"The question is never whether innovation is important. It is whether the organization has the process and the will to pursue the right innovations — before the window closes and others have moved."
— BUILDING THE CAPABILITY
Innovation that compounds requires more than a good strategy. It requires a repeatable, flexible and dynamic operating model.
01
Investment thesis and portfolio design
A clear, defensible statement of the growth bets worth making — the technology horizons and market adjacencies that will define the next platform. Built before the first investment, not after.
02
Governance and decision rights
Who decides what, at which stage, and on what criteria. The structure that allows innovation to move at the speed it requires — without losing organizational coherence.
03
Intake and qualification process
How opportunities enter the funnel, how they are evaluated against the thesis, and which ones earn the investment of time and resource to develop further.
04
Conversion — from pilot to platform
Most corporate innovation fails at the transition from pilot to scale. Vaxa designs the conversion pathway — the conditions, triggers, and organizational design that makes scaling possible.
— Ecosystem Access
Get access to Vaxa's ecosystems of Investors and Startups across all Industries.
The ventures worth backing don't wait for corporate programs to find them. Vaxa's ecosystem network puts them in reach before they are.
INVESTOR TYPES
350,000
VC, Corporate Venture Capital, PE, Soverign Funds, Family Offices
STARTUP COMPANIES
900,000
All stages: Pre-seed, Seed, All Series to pre-IPO
Technology domains
50+ Domains
AI/ML · Biotechnology · Genomics & Gene Editing · Advanced Materials · Clean Energy · Quantum Computing · Robotics & Automation · Digital Health · Semiconductors · Space Technology · Agritech · Fintech · Medtech · Cybersecurity · Climate Tech, and more
INDUSTRIES
20+
Enterprise Software · Life Sciences · Consumer Goods · Telecommunications · Financial Services · Energy · Automotive · Healthcare · Industrial · Retail · Media & Entertainment · Logistics · Real Estate · Education · Defence, and more
Stay ahead of what's forming. Subscribe to Vaxa Insights — our look at the critical issues and emerging opportunities facing businesses today.